Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies

J Clin Oncol. 2016 Mar 20;34(9):895-7. doi: 10.1200/JCO.2015.65.2255. Epub 2016 Jan 19.

Authors

Jonas Bergh¹, Kathleen I Pritchard², David Cameron³

Affiliations

¹ Karolinska Institutet and University Hospital, Stockholm, Sweden jonas.bergh@ki.se.
² Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada.
³ University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom.

PMID: 26786914
DOI: 10.1200/JCO.2015.65.2255

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Breast Neoplasms / epidemiology*
Female
Humans
Neoplasm Recurrence, Local / epidemiology*